Latest News
Anixa Biosciences, Inc.
- Anixa Biosciences (ANIX) CEO Amit Kumar Buys 8,000 Shares, Insider Ownership Rises to 680,000 Shares
- Anixa Biosciences CEO Amit Kumar buys $21,760 in stock
- Form 4 Anixa Biosciences Inc: Amit Kumar (Director, CEO) For: 22 October
- Anixa Biosciences, Inc. (ANIX) Earnings Date, Reports and Estimates
- Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer Vaccine
- Anixa's Dr. Conejo-Garcia to present on ovarian cancer immunotherapy at Nov conference
- Anixa's CAR-T therapy shows stable disease in o...
- Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial
- Anixa Biosciences And 2 Other Penny Stocks Worth Watching
- Anixa Biosciences (ANIX) CEO buys shares, bringing his direct holdings to 672,000
- Anixa Biosciences CEO Amit Kumar buys $19,460 in common stock
- Anixa Biosciences director Lewis Titterton Jr. buys $131,906 in stock By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →